title: Visual results in children treated for macular retinoblastoma.
abstract: OBJECTIVE
  To evaluate the results of patching treatment in children with macular retinoblastoma in one eye.
  
  
  METHODS
  Fifteen children affected by macular retinoblastoma received instructions for patching treatment for amblyopia. Data were collected on age at diagnosis of the tumor, presence of unilateral or bilateral disease, area of posterior pole involvement by the scar of the regressed tumor and its relationship to the fovea; and the onset, duration, and compliance of patching. The visual acuities recorded were expressed in logMAR (logarithm minimum angle of resolution) equivalents.
  
  
  RESULTS
  Twelve children (80%) had bilateral retinoblastoma with the macular involved in one eye and three children had unilateral macular tumors. The median age at which patching was initiated was 15 months (range 4-36). Compliance to patching was good in 80% of children, with a median duration of 4 h (range 0.5-8) per day, 7 days per week, with total occlusion of the better eye. The median percentage of posterior pole involvement was 34% (range 11-100%). Eighty percent of children had some improvement in their visual acuity, and of the children in whom final logMAR acuity was recorded, 73% had an acuity of 1.0 logMAR or better and 53% an acuity of 0.5 logMAR or better after patching. There was no evidence of association between age of patient, sex, duration of patching, or percentage of posterior pole involvement and the improvement in visual acuity.
  
  
  CONCLUSIONS
  In spite of the macular involvement of eyes with retinoblastoma, some visual recovery was achieved in 80% of children. Hence a trial of patching therapy is recommended for all children with involvement of the macula by retinoblastoma.
authors.affiliation: Department of Ophthalmology, The Hospital for Sick Children, Toronto, Ontario, Canada. patrickowatts@hotmail.com
authors.forename: P
authors.initials: P
authors.lastname: Watts
authors.forename: C
authors.initials: C
authors.lastname: Westall
authors.forename: L
authors.initials: L
authors.lastname: Colpa
authors.forename: L
authors.initials: L
authors.lastname: MacKeen
authors.forename: M
authors.initials: M
authors.lastname: Abdolell
authors.forename: B
authors.initials: B
authors.lastname: Gallie
authors.forename: E
authors.initials: E
authors.lastname: Héon
mesh_terms: D000550:Amblyopia / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D001458:Bandages; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008266:Macula Lutea; D008297:Male; D010349:Patient Compliance; D020127:Recovery of Function; D019572:Retinal Neoplasms / Q000150:complications / Q000628:therapy*; D012175:Retinoblastoma / Q000150:complications / Q000628:therapy*; D012189:Retrospective Studies; D012683:Sensory Deprivation; D014792:Visual Acuity